The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-N1-(10-(4-chlorophenyl)-3-(pyridin-3-ylamino)phenazin-2(10H)-ylidene)-N3,N3-dimethylpropane-1,3-diamine ID: ALA4859835
Max Phase: Preclinical
Molecular Formula: C28H27ClN6
Molecular Weight: 483.02
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)CCC/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1cccnc1
Standard InChI: InChI=1S/C28H27ClN6/c1-34(2)16-6-15-31-24-18-28-26(17-25(24)32-21-7-5-14-30-19-21)33-23-8-3-4-9-27(23)35(28)22-12-10-20(29)11-13-22/h3-5,7-14,17-19,32H,6,15-16H2,1-2H3/b31-24+
Standard InChI Key: COMPQROOZQLDHI-QFMPWRQOSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
9.0223 -5.5299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0211 -6.3569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7356 -6.7694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7337 -5.1175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4487 -5.5263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4475 -6.3589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1639 -6.7739 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1663 -5.1088 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8861 -6.3569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1651 -4.2892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8809 -3.8776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8813 -3.0539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1666 -2.6408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4503 -3.0574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4534 -3.8798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6051 -6.7761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3251 -6.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3293 -5.5282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6071 -5.1092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8809 -5.5244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0377 -6.7774 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0347 -7.6019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3181 -8.0073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3148 -8.8310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0279 -9.2467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7458 -8.8325 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7456 -8.0101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0448 -5.1186 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0478 -4.2941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7633 -3.8845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7663 -3.0599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4821 -2.6526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4871 -1.8364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1920 -3.0735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1656 -1.8163 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 8 1 0
6 7 1 0
7 9 2 0
20 8 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 10 1 0
9 16 1 0
9 20 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 2 0
17 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
18 28 2 0
28 29 1 0
30 29 1 0
30 31 1 0
32 31 1 0
32 34 1 0
32 33 1 0
13 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 483.02Molecular Weight (Monoisotopic): 482.1986AlogP: 5.77#Rotatable Bonds: 7Polar Surface Area: 58.34Molecular Species: BASEHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 9.28CX LogP: 4.79CX LogD: 2.89Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.24Np Likeness Score: -1.27
References 1. Koval A, Bassanini I, Xu J, Tonelli M, Boido V, Sparatore F, Amant F, Annibali D, Leucci E, Sparatore A, Katanaev VL.. (2021) Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo., 222 [PMID:34116325 ] [10.1016/j.ejmech.2021.113562 ]